These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11328891)

  • 1. When should we start erythropoietin therapy?
    O'Riordan E; Foley RN
    Nephrol Dial Transplant; 2001 May; 16(5):891-2. PubMed ID: 11328891
    [No Abstract]   [Full Text] [Related]  

  • 2. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Padovese P; Gallieni M; Galmozzi C; Brancaccio D
    Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238
    [No Abstract]   [Full Text] [Related]  

  • 3. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythropoietin and dialyzed patients].
    Kreis H
    Rev Prat; 1989 Dec; 39(28):2530-1. PubMed ID: 2602881
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human erythropoietin and haemodialyser re-use.
    Dos Santos JP; Prata MM; Sousa FT; Barbas JV
    Nephron; 1990; 56(4):447-8. PubMed ID: 2080010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin, oxidative metabolism and dialysis.
    Ionova D; Sepetlieva K; Tcachev K
    Nephron; 2000 Dec; 86(4):544. PubMed ID: 11124624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of erythropoietin administration in uremia.
    Gurland HJ; Samtleben W; Schmidt B
    Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin: the developing story.
    Cotes PM
    Br Med J (Clin Res Ed); 1988 Mar; 296(6625):805-6. PubMed ID: 3130919
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin and its clinical promise.
    Erslev AJ; Schuster SJ; Caro J
    Eur J Haematol; 1989 Nov; 43(5):367-73. PubMed ID: 2693128
    [No Abstract]   [Full Text] [Related]  

  • 18. Should target hemoglobin levels in dialysis patients be lowered to 9-10 g/dl?
    Fishbane S; Masani NN; Hazzan AD
    Semin Dial; 2014; 27(3):282-4. PubMed ID: 24666175
    [No Abstract]   [Full Text] [Related]  

  • 19. The modality of dialysis treatment: does it influence the response to erythropoietin treatment?
    Locatelli F; Del Vecchio L; Andrulli S
    Nephrol Dial Transplant; 2001 Oct; 16(10):1971-4. PubMed ID: 11572880
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
    Djordjević VB; Pavlović D; Pejović M; Lecić N; Koraćević D; Djordjević V; Stefanović V
    Nephron; 1993; 65(3):497-8. PubMed ID: 8290015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.